Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Dehm

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Cancer Research|October 6, 2023
Prostate Cancer Progression Relies on the Mitotic Kinase Citron KinaseChitra Rawat, Salma Ben-Salem, Nidhi Singh, et al.
European Urology Oncology|December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerJacob J Orme, Fadi Taza, Navonil De Sarkar, et al.
Journal of the National Cancer Institute|December 15, 2015
Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic TargetMohammad Asim, Charles E Massie, Folake Orafidiya, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Synergistic RAS-MAPK and AKT Activation in MYC-Driven Tumors via Adjacent PVT1 RearrangementsAshutosh Tiwari, Utkarsha Paithane, Jordan Friedlein, et al.
Cancer Discovery|April 1, 2025
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical OutcomesMarina N Sharifi, Jamie M Sperger, Amy K Taylor, et al.
Cancer Discovery|February 6, 2025
High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomesMarina N Sharifi, Jamie M Sperger, Amy K Taylor, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Cell|July 24, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate CancerDavid A Quigley, Ha X Dang, Shuang G Zhao, et al.
Cell|October 20, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate CancerDavid A Quigley, Ha X Dang, Shuang G Zhao, et al.
Nature Genetics|July 15, 2020
The DNA methylation landscape of advanced prostate cancerShuang G Zhao, William S Chen, Haolong Li, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Cancer Research|October 6, 2023
Prostate Cancer Progression Relies on the Mitotic Kinase Citron KinaseChitra Rawat, Salma Ben-Salem, Nidhi Singh, et al.
European Urology Oncology|December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerJacob J Orme, Fadi Taza, Navonil De Sarkar, et al.
Journal of the National Cancer Institute|December 15, 2015
Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic TargetMohammad Asim, Charles E Massie, Folake Orafidiya, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Synergistic RAS-MAPK and AKT Activation in MYC-Driven Tumors via Adjacent PVT1 RearrangementsAshutosh Tiwari, Utkarsha Paithane, Jordan Friedlein, et al.
Cancer Discovery|April 1, 2025
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical OutcomesMarina N Sharifi, Jamie M Sperger, Amy K Taylor, et al.
Cancer Discovery|February 6, 2025
High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomesMarina N Sharifi, Jamie M Sperger, Amy K Taylor, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Cell|July 24, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate CancerDavid A Quigley, Ha X Dang, Shuang G Zhao, et al.
Cell|October 20, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate CancerDavid A Quigley, Ha X Dang, Shuang G Zhao, et al.
Nature Genetics|July 15, 2020
The DNA methylation landscape of advanced prostate cancerShuang G Zhao, William S Chen, Haolong Li, et al.
Pageof 13